Rheumatology News

The Centers for Medicare & Medicaid Services announced lower Medicare Part D prices for 10 drugs that will take effect in 2026, according to a press release.

Among patients with systemic autoimmune disease in a large, real-world cohort, 29.8% reported long COVID, with frequent impacts to quality of life, following infection, according to data published in The Journal of Rheumatology.

Infections account for most in-hospital mortality in childhood systemic lupus erythematosus, with patients exhibiting lupus nephritis or end-stage renal disease at increased risk, according to data published in The Journal of Rheumatology.

Opioid use in patients with autoimmune rheumatic disease has decreased 15% annually since 2014, while use of non-opioid options for pain management has either increased or stabilized, according to data published in The Lancet Rheumatology.

Intravenous immunoglobulin treatment may benefit skin, musculoskeletal and gastrointestinal manifestations of systemic sclerosis, with low risks for adverse events, according to data published in Seminars in Arthritis and Rheumatism.

“Aggressive” combination therapy for gastroesophageal reflux disease improved survival among patients with systemic sclerosis and interstitial lung disease, according to data published in Arthritis Research & Therapy.

The FDA has approved an investigational new drug application for Eque-cel, an autologous T-cell injection, in patients with systemic lupus erythematosus and lupus nephritis, according to a press release from the manufacturer.

As your paycheck grows, so does your discretionary spending and saving. While it is easy to spend, it is not always clear where to invest your next dollar intended for future spending.

The Healio Rheumatology staff have won the APEX Award for Writing/Topics – Health & Medical Writing for the cover story, “‘Moral imperative’ to address physician burnout emerges in wake of COVID-19 pandemic.”

Welcome to the first-ever Healio Rheum for Debate, in which we ask experts to take opposing sides and match wits on major topics in the field of rheumatology.